Category: Cell and gene therapy
Highlights of ASCO 2025 Translating research into real-world results for cancer patients I joined over 45,000 oncology professionals at McCormick Read Now
Driving Innovation in Radiopharmaceutical Therapies Oncology clinical research is complex, demanding, and continually evolving. Bringing effective radiopharmaceutical therapies from proof-of-concept Read Now
Developing Next-generation Therapies for Breast Cancer Patients Breast cancer is the second most common malignancy worldwide and the number one cancer in Read Now
Helping to Develop Cell Therapies Catalyst Oncology is a specialty oncology CRO devoting time, energy, and capital to supporting biotechs Read Now
CRO Support for XRad Therapeutics XRad Therapeutics announced first patient dosed in Phase 1a clinical trial of XRD-0394 for metastatic, Read Now
Partnership with Cell and Gene Therapy Catapult Aptus Clinical and Cell and Gene Therapy Catapult announce their clinical service collaboration to support Read Now